ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $3,513,000 | -23.6% | 37,795 | -51.1% | 0.02% | -24.0% |
Q3 2021 | $4,601,000 | -13.4% | 77,268 | -0.9% | 0.02% | -10.7% |
Q2 2021 | $5,316,000 | -4.9% | 77,953 | -3.2% | 0.03% | -9.7% |
Q1 2021 | $5,589,000 | -14.7% | 80,548 | -5.6% | 0.03% | -20.5% |
Q4 2020 | $6,555,000 | -47.1% | 85,316 | -48.5% | 0.04% | -50.0% |
Q3 2020 | $12,389,000 | -2.1% | 165,651 | -17.6% | 0.08% | -3.7% |
Q2 2020 | $12,658,000 | +57.1% | 201,080 | +4.8% | 0.08% | +42.1% |
Q1 2020 | $8,056,000 | -39.9% | 191,817 | -35.0% | 0.06% | -6.6% |
Q4 2019 | $13,410,000 | +303.2% | 295,242 | +306.2% | 0.06% | +306.7% |
Q3 2019 | $3,326,000 | +1483.8% | 72,676 | +1933.5% | 0.02% | +1400.0% |
Q2 2019 | $210,000 | +16.7% | 3,574 | -11.1% | 0.00% | 0.0% |
Q1 2019 | $180,000 | -43.6% | 4,019 | -50.9% | 0.00% | 0.0% |
Q4 2018 | $319,000 | -84.8% | 8,185 | -82.1% | 0.00% | -87.5% |
Q3 2018 | $2,105,000 | -59.3% | 45,732 | -61.4% | 0.01% | -60.0% |
Q2 2018 | $5,167,000 | +3.7% | 118,504 | -6.1% | 0.02% | 0.0% |
Q1 2018 | $4,983,000 | +16.1% | 126,161 | -0.2% | 0.02% | +25.0% |
Q4 2017 | $4,293,000 | +37.6% | 126,387 | +3.3% | 0.02% | +33.3% |
Q3 2017 | $3,121,000 | +51.1% | 122,377 | -0.0% | 0.01% | +50.0% |
Q2 2017 | $2,065,000 | – | 122,384 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |